Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Heudel

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|February 20, 2025
[Impact and potential of digital technology in mind-body approaches for cancer care]Céline Ubelmann, Pierre Heudel
JCO Clinical Cancer Informatics|March 24, 2025
Leveraging Digital Technology to Enhance Mind-Body Approaches in Cancer TreatmentPierre Heudel, Céline Ubelmann
Bulletin Du Cancer|September 11, 2024
[Optimization of coordination in oncology: The place of territorial professional health communities]Sophie Lantheaume, William Lebossé, Jean-Eudes Mory, et al.
Bulletin Du Cancer|November 7, 2016
[The ConSoRe project supports the implementation of big data in oncology]Pierre Heudel, Alain Livartowski, Patrick Arveux, et al.
International Journal of Clinical Oncology|September 3, 2010
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factorsPierre Heudel, Sebastien Cimarelli, Anthony Montella, et al.
PLOS Digital Health|December 19, 2023
From data strategy to implementation to advance cancer research and cancer care: A French comprehensive cancer center experiencePierre Heudel, Hugo Crochet, Thierry Durand, et al.
JMIR Cancer|October 21, 2025
Impact of Immune Checkpoint Inhibitors on Second Primary Cancer Risk in Patients With Metastatic Lung Cancer Using Real-World Data From the TriNetX Network: Retrospective Cohort StudyPierre Heudel, Gema Hernandez, Olivier Denquin, et al.
Bulletin Du Cancer|June 30, 2015
[Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015]Hélène Vanacker, Olivia Bally, Loay Kassem, et al.
BMC Urology|June 19, 2009
Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experiencePierre Heudel, Fadi El Karak, Nabil Ismaili, et al.
Bulletin Du Cancer|August 22, 2022
[Survey on the practice of medical teleconsultation in oncology in Auvergne Rhône Alpes]Sophie Lantheaume, William Lebosse, Louis Doublet, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|February 20, 2025
[Impact and potential of digital technology in mind-body approaches for cancer care]Céline Ubelmann, Pierre Heudel
JCO Clinical Cancer Informatics|March 24, 2025
Leveraging Digital Technology to Enhance Mind-Body Approaches in Cancer TreatmentPierre Heudel, Céline Ubelmann
Bulletin Du Cancer|September 11, 2024
[Optimization of coordination in oncology: The place of territorial professional health communities]Sophie Lantheaume, William Lebossé, Jean-Eudes Mory, et al.
Bulletin Du Cancer|November 7, 2016
[The ConSoRe project supports the implementation of big data in oncology]Pierre Heudel, Alain Livartowski, Patrick Arveux, et al.
International Journal of Clinical Oncology|September 3, 2010
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factorsPierre Heudel, Sebastien Cimarelli, Anthony Montella, et al.
PLOS Digital Health|December 19, 2023
From data strategy to implementation to advance cancer research and cancer care: A French comprehensive cancer center experiencePierre Heudel, Hugo Crochet, Thierry Durand, et al.
JMIR Cancer|October 21, 2025
Impact of Immune Checkpoint Inhibitors on Second Primary Cancer Risk in Patients With Metastatic Lung Cancer Using Real-World Data From the TriNetX Network: Retrospective Cohort StudyPierre Heudel, Gema Hernandez, Olivier Denquin, et al.
Bulletin Du Cancer|June 30, 2015
[Advanced luminal breast cancer (hormone receptor-positive, HER2 negative): New therapeutic options in 2015]Hélène Vanacker, Olivia Bally, Loay Kassem, et al.
BMC Urology|June 19, 2009
Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experiencePierre Heudel, Fadi El Karak, Nabil Ismaili, et al.
Bulletin Du Cancer|August 22, 2022
[Survey on the practice of medical teleconsultation in oncology in Auvergne Rhône Alpes]Sophie Lantheaume, William Lebosse, Louis Doublet, et al.
Pageof 3